- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2020-10-15 16:21:12
- Reporting Period:
- Accepted Time:
- 2020-10-15 16:21:12
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|320187||Nike Inc.||NKE||Rubber & Plastics Footwear (3021)||930584541|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1487557||K Hilary Krane||One Bowerman Dr |
Beaverton OR 97005-0979
|Evp, Cao & General Counsel||No||Yes||No||No|
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Class B Common Stock||Acquisiton||2020-10-14||11,000||$31.68||166,855||No||4||M||Direct|
|Class B Common Stock||Disposition||2020-10-14||11,000||$129.53||155,855||No||4||S||Direct|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Class B Common Stock||Non-Qualified Stock Option (Right to Buy)||Disposition||2020-10-14||11,000||$0.00||11,000||$31.68|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
Reported Non-Derivative Holdings
|Sec. Name||Remaning Holdings||Nature of Ownership||Explanation|
|Class B Common Stock||119||Indirect||by Retirement Plan|
- Exercise and sale pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the last day of the second month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
- Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.
- Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.
- Stock Option granted on 07/19/2013 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.